{"issuance_frequency":"","notes_translated":{"fr":"Les taux d’infections transmises sexuellement (ITS) continuent d’augmenter à l’échelle mondiale, y compris au Canada. La gonorrhée est l’ITS résistante aux médicaments la plus fréquemment signalée et la deuxième infection bactérienne transmissible sexuellement en fréquence au Canada, avec plus de 19 000 cas déclarés en 2015\r\n","en":"Rates of sexually transmitted infections (STI) continue to increase globally, including in Canada. Gonorrhea is the most commonly reported drug resistant STI and the second most common bacterial STI in Canada with over 19,000 cases reported in 2015.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","metadata_created":"2019-05-31T15:11:54.216133","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-05-31T15:11:54.216145","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-05-31","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Les taux d’infections transmises sexuellement","ITS","gonorrhée","Neisseria gonorrhoeae","N. gonorrhoeae"],"en":["sexually transmitted infections","Gonorrhea","STI","Neisseria gonorrhoeae","N. gonorrhoeae"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015","en":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fd7c5ca3-498b-4c07-a91d-548357b929e5","related_relationship":"","name_translated":{"fr":"Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) - Résultats de 2014 et 2015","en":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015","language":["en"],"created":"2019-05-31T15:11:55.406015","url":"https://www.canada.ca/en/public-health/services/publications/diseases-conditions/2014-2015-report-enhanced-surveillance-antimicrobial-resistant-gonorrhea.html#a1","last_modified":null,"position":0,"revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c93ffb6f-0f7c-4c3e-aa9d-e4d64d2e40ae","related_relationship":"","name_translated":{"fr":"Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) - Résultats de 2014 et 2015","en":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015","language":["fr"],"created":"2019-05-31T15:11:55.406024","url":"https://www.canada.ca/fr/sante-publique/services/publications/maladies-et-affections/2014-2015-rapport-systeme-surveillance-accrue-resistance-gonorrhee-antimicrobiens.html","last_modified":null,"position":1,"revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cc6da18d-21a5-461d-baec-181b266e4586","related_relationship":"","name_translated":{"fr":"Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) - Résultats de 2014 et 2015","en":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015","language":["en"],"created":"2019-05-31T15:11:55.406027","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/diseases-conditions/2014-2015-report-enhanced-surveillance-antimicrobial-resistant-gonorrhea/2014-2015-report-gonorrhea-eng.pdf","last_modified":null,"position":2,"revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"77e10560-ad64-4d68-b5d4-64e511a6be43","related_relationship":"","name_translated":{"fr":"Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) - Résultats de 2014 et 2015","en":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015","language":["fr"],"created":"2019-05-31T15:11:55.406029","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/diseases-conditions/2014-2015-report-enhanced-surveillance-antimicrobial-resistant-gonorrhea/2014-2015-report-gonorrhea-fra.pdf","last_modified":null,"position":3,"revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f6990d20-1c74-4e0b-8585-10c0fc4b0025","related_relationship":"","name_translated":{"fr":"Surveillance nationale de la sensibilité aux antimicrobiens de Neisseria gonorrhoeae : Rapport sommaire annuel de 2017","en":"National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae in Canada: Annual Summary 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae in Canada: Annual Summary 2017","language":["en"],"created":"2019-05-31T15:11:55.406032","url":"https://www.canada.ca/en/public-health/services/publications/drugs-health-products/national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2017.html","last_modified":null,"position":4,"revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9805d1e3-dce6-4e24-a5e6-9419108c0017","related_relationship":"","name_translated":{"fr":"Surveillance nationale de la sensibilité aux antimicrobiens de Neisseria gonorrhoeae : Rapport sommaire annuel de 2017","en":"National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae in Canada: Annual Summary 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae in Canada: Annual Summary 2017","language":["fr"],"created":"2019-05-31T15:11:55.406035","url":"https://www.canada.ca/fr/sante-publique/services/publications/medicaments-et-produits-sante/surveillance-nationale-sensibilite-aux-antimicrobiens-neisseria-gonorrhoeae-rapport-sommaire-annuel-2017.html","last_modified":null,"position":5,"revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57","resource_type":"website"}],"place_of_publication":[],"num_resources":6,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2049-04-29 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"2fab1ffd-96c6-46b1-862d-08d9e80e015a","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Rates of sexually transmitted infections (STI) continue to increase globally, including in Canada. Gonorrhea is the most commonly reported drug resistant STI and the second most common bacterial STI in Canada with over 19,000 cases reported in 2015.\r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) - Results from 2014 and 2015","revision_id":"c213669b-2cdb-4ef4-afe9-3b2b5230aa57"}